Nalaganje...
A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma
Lenalidomide (also known as Revlimid(®), CC-5013) is an immunomodulatory derivative of thalidomide and has more potent anti-tumor and anti-inflammatory effects than thalidomide. The molecular mechanisms of anti-tumor activity of lenalidomide have been extensively studied in multiple myeloma (MM) bot...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2008
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2503648/ https://ncbi.nlm.nih.gov/pubmed/18728702 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|